Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Other Liabilities

Amag Pharmaceuticals Other Liabilities Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Other Liabilities from 2010 to 2020.
  • Amag Pharmaceuticals Other Liabilities for the quarter ending June 06, 2020 was $1m a -556.76% decrease of -5m year over year
  • Amag Pharmaceuticals Other Liabilities for the last 12 months ending June 06, 2020 was $1m a -556.76% decrease of -5m year over year
  • Amag Pharmaceuticals Annual Other Liabilities for 2019 was $0m a -1,503.37% decrease of -1m from 2018
  • Amag Pharmaceuticals Annual Other Liabilities for 2018 was $1m a -6,747.30% decrease of -96m from 2017
  • Amag Pharmaceuticals Annual Other Liabilities for 2017 was $98m a -172.03% decrease of -168m from 2016
Other Balance Sheet Metrics:
  • Amag Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $1,216m a -52.43% decrease of -637m year over year
  • Amag Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $762m a -3.67% decrease of -28m year over year
View Chart On Koyfin

Quarterly AMAG Other Liabilities Data

06/2020$1m
03/2020$1m
12/2019$0m
09/2019$5m
06/2019$6m
03/2019$5m
12/2018$1m
09/2018$2m
06/2018$100m
03/2018$47m

Annual AMAG Other Liabilities Data

2019$0m
2018$1m
2017$98m
2016$266m
2015$324m
2014$301m
2013$60m
2012$52m
2011$48m
2010$54m